| # | Drug | Count |
|---|---|---|
| 0 | BINIMETINIB | 2 |
| 1 | ENCORAFENIB | 2 |
| 2 | NIVOLUMAB | 2 |
| 3 | EMPAGLIFLOZIN | 1 |
| 4 | OMALIZUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BINIMETINIB | 2 | 0.0003 |
| 1 | ENCORAFENIB | 2 | 0.0002 |
| 2 | NIVOLUMAB | 2 | 0.0000 |
| 3 | EMPAGLIFLOZIN | 1 | 0.0000 |
| 4 | OMALIZUMAB | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 |
| 1 | Anti-IgE [EPC] | 1 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 1 | Anti-IgE [EPC] | 1 | 0.0000 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |